Preview

Drug development & registration

Advanced search

Guidelines for Promoting the Implementation of Pharmaceutical Quality Systems at EAEU Enterprises Through the Management of the Engagement of Production Personnel

https://doi.org/10.33380/2305-2066-2021-10-1-136-141

Abstract

Introduction. The publication is devoted to the topical organizational and personnel issues of the implementation of the pharmaceutical quality system (PQS). The relevance of the study is due to the high importance of quality assurance in the development, production and release of drugs into circulation.

Aim. The aim: to develop guidelines for organizational and personnel assistance in the implementation of pharmaceutical quality systems at enterprises of the Eurasian Union (EAEU) for the production of medicines (drugs) through the toolkit for engaging production personnel in the development of PQS.

Materials and methods. Personnel engagement was assessed based on the engagement index; the benchmarking method was used when studying the impact of the engagement of production personnel on the economic indicators of corporate development (indicators of engagement and related economic indicators of “Akrikhin”, “Ozon” were compared with a panel of similar indicators for 12 pharmaceutical enterprises of the EAEU).

Results and discussion. The important role of ensuring an increase in the engagement of production personnel in the development of PQS as a tool for sustainable provision of the effectiveness of the implementation of PQS and standards of good manufacturing practice (GMP) at drug production enterprises is stated. Taking into account the experience of forming quality circles in classical Japanese management, an innovative toolkit for managing the engagement of production personnel is proposed, based on the formation of employee communities, coordination and management of their engagement and development through the corporate portal of a pharmaceutical enterprise, as well as membership in closed clubs of ‘quality leaders’.

Conclusion. Management of communities (small groups) of production workers is considered as a tool for improving the organizational and personnel support for the implementation and improvement of PQS / GMP at the EAEU pharmaceutical manufacturers. Through the communities, it is proposed to simultaneously manage the engagement, loyalty and job satisfaction of production personnel; community members, through the exchange of best manufacturing practices, ideas and opinions on the development of PQS and the improvement of nuclear quality assurance practices, will stimulate themselves and other production workers to consistently ensure the quality of manufactured drugs. The expected result is a steady increase in the quality of manufactured drugs, adherence of production personnel to the quality philosophy, creation of conditions for the growth of labour productivity of production personnel of pharmaceutical enterprises.

About the Authors

V. A. Smirnov
State Institute of Drugs and Good Practices
Russian Federation

Vladimir A. Smirnov

6, Lavrov lane, Moscow, 109044



V. V. Goryachkin
State Institute of Drugs and Good Practices
Russian Federation

Vyacheslav V. Goryachkin

6, Lavrov lane, Moscow, 109044



V. N. Shestakov
State Institute of Drugs and Good Practices
Russian Federation

Vladislav N. Shestakov

6, Lavrov lane, Moscow, 109044



R. A. Abramovich
Peoples Friendship University of Russia (RUDN University)
Russian Federation

Rimma A. Abramovich

6, Mikluho-Maklaya str., Moscow, 117198



References

1. Pai D.R., Kamath K., Subramanyam E.V., Shabaraya A.R. Personnel Training for Pharmaceutical Industry. International Journal of Pharmaceutical Quality Assurance. 2016;7(03):55-61.

2. Lawler E. E. Total quality management and employee involvement: are they compatible? Academy of Management Perspectives. 1994;8(1):68–76. DOI: 10.5465/ame.1994.9411302396.

3. Neirotti P. Work intensification and employee involvement in lean production: New light on a classic dilemma. The International Journal of Human Resource Management. 2020;31(15):1958–83. DOI: 10.1080/09585192.2018.1424016.

4. Sorenson S. How employee engagement drives growth. Gallup business journal. 2013;1:1–4.

5. Gildeeva G. N., Belostotskiy A. V., Andreeva D. M. Relevant Changes in the Pharmacovigilance System in Russia and the Eurasian Economic Union (EAEU) International Journal of Pharmaceutical Quality Assurance. 2019;10(03):34–37.

6. Macey W. H., Schneider B. The meaning of employee engagement. Industrial and organizational Psychology. 2008;1(1):3–10. DOI: 10.1111/j.1754-9434.2007.0002.x.

7. Chiarini A. Relationships between total quality management and Six Sigma inside European manufacturing companies: a dedicated survey. International Journal of Productivity and Quality Management. 2013;11(2):179–194. DOI: 10.1504/IJPQM.2013.052023.

8. Bouwman-Boer Y., Andersen L. M. Pharmaceutical quality systems. In: Bouwman-Boer Y., Fenton-May V., Le Brun P. (eds). Practical Pharmaceutics. New York: Springer; 2015. P. 769–796. DOI: 10.1007/978-3-319-15814-3_35.

9. Oluwadare O.P., Ola-Olorun O.J., Oluwale B.A. Assessment of Total Quality Management Adoption Level in Pharmaceutical Manufacturing Companies in Southwestern Nigeria. JERA 2019;43:168–77. DOI:10.4028/www.scientific.net/jera.43.168.

10. Jyoti S., Sarthak S. Human Resource Management in Japan. Advances in Management. 2019;12(1):48–53.


Supplementary files

Review

For citations:


Smirnov V.A., Goryachkin V.V., Shestakov V.N., Abramovich R.A. Guidelines for Promoting the Implementation of Pharmaceutical Quality Systems at EAEU Enterprises Through the Management of the Engagement of Production Personnel. Drug development & registration. 2021;10(1):136-141. (In Russ.) https://doi.org/10.33380/2305-2066-2021-10-1-136-141

Views: 1654


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2305-2066 (Print)
ISSN 2658-5049 (Online)